Grutters et al recently investigated the role of early health economic modelling of health technologies by undertaking a secondary analysis of health economic modelling assessments performed by their group. Our commentary offers a broad perspective on the potential utility of early health economic modelling to inform health technology assessment (HTA) and decision-making around reimbursement of new health technologies. Further we provide several examples to compliment Grutters and colleagues' observations
Worldwide, billions of dollars are invested in medical product development\ud and there is an increa...
Our contribution aims to explore the different ways in which early economic data can inform public h...
The current system of health technology development is characterised by multiple misalignments. The ...
Grutters et al recently investigated the role of early health economic modelling of hea...
In this commentary, we discuss early stage assessments of innovative medical technologies...
This commentary considers the positive and negative consequences of early economic modelling and exp...
In a review recently published in this journal, Grutters et al outline the scope and impact of their...
A recent paper by Grutters et al makes the case for early health economic modeling in the developmen...
Early economic modelling has long been recommended to aid research and development (R&D)...
In a review recently published in this journal, Grutters et al outline the scope and impact of their...
Background: To assess whether early health economic modeling helps to distinguish those healthcare i...
Grutters et al show that economic assessments can inform the development of new health ...
Early health technology assessment (HTA), which includes all methods used to inform industry and oth...
Early health technology assessment (HTA), which includes all methods used to inform industry and oth...
Worldwide, billions of dollars are invested in medical product development and there is an increasin...
Worldwide, billions of dollars are invested in medical product development\ud and there is an increa...
Our contribution aims to explore the different ways in which early economic data can inform public h...
The current system of health technology development is characterised by multiple misalignments. The ...
Grutters et al recently investigated the role of early health economic modelling of hea...
In this commentary, we discuss early stage assessments of innovative medical technologies...
This commentary considers the positive and negative consequences of early economic modelling and exp...
In a review recently published in this journal, Grutters et al outline the scope and impact of their...
A recent paper by Grutters et al makes the case for early health economic modeling in the developmen...
Early economic modelling has long been recommended to aid research and development (R&D)...
In a review recently published in this journal, Grutters et al outline the scope and impact of their...
Background: To assess whether early health economic modeling helps to distinguish those healthcare i...
Grutters et al show that economic assessments can inform the development of new health ...
Early health technology assessment (HTA), which includes all methods used to inform industry and oth...
Early health technology assessment (HTA), which includes all methods used to inform industry and oth...
Worldwide, billions of dollars are invested in medical product development and there is an increasin...
Worldwide, billions of dollars are invested in medical product development\ud and there is an increa...
Our contribution aims to explore the different ways in which early economic data can inform public h...
The current system of health technology development is characterised by multiple misalignments. The ...